Merge, LLC

Clinical trial patients being the ones who endure the burden of their disease & encounter trial barriers is “a national problem [that] requires a local solution,” says Mimi Fenton, CEO of Cedar Health Research. Fenton found that when gaining community trust was prioritized, underrepresented groups were more eager to engage in trials.

In an Ecosystem of Trust, Trial Enthusiasm can ‘Spread Like Wildfire’ Discover the Latest News in Clinical Research, Clinical Trials, Medical Informatics, & More. Clinical Research News Online Provides Daily Insights, News, & Analysis for the Clinical Research Industry.

The FDA issued a guide to enhance how clinical trials enroll underrepresented patients. Now, broadening I/E criteria is encouraged to embody a more inclusive, real-world sample of the population. Underrepresentation must be challenged to produce viable evidence & real‑world relevance going forward. Read on:

FDA Issues Final Guidance On Clinical Trial Participation: What You Need To Do Now On December 15, 2025, the FDA finalized its guidance Enhancing Participation in Clinical Trials, formally updating expectations for enrollment and trial design. Heres what you can do now.

It’s ! To all the physicians and clinical researchers, thank you for your long hours, your expertise, and the difference you make in so many lives. 🩺 💙🥼